News Conference News ISC 2024 Speedier Anticoagulation Reversal Tied to Better ICH Outcomes Todd Neale February 15, 2024
News Conference News ISC 2022 Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis Todd Neale February 17, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Conference News ISC 2021 Ischemic Stroke, TIA Risk in COVID-19 Lower Than Previously Seen Todd Neale March 22, 2021
News Conference News ISC 2021 Rising Endocarditis and Neurovascular Events Linked to Opioid Epidemic Todd Neale March 16, 2021
News Conference News ISC 2020 Antihypertensive Treatment is Subpar After ICH Todd Neale February 19, 2020
News Conference News ISC 2019 Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects Todd Neale February 13, 2019
News Conference News ISC 2018 More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs Todd Neale January 27, 2018
News Conference News ISC 2018 COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke Todd Neale January 25, 2018
News Conference News ISC 2017 Definitive Trials Spur Sharp Uptick in Use of Endovascular Therapy for Acute Ischemic Stroke Todd Neale March 02, 2017
News Conference News ISC 2017 NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin Todd Neale March 01, 2017
News Conference News ISC 2016 To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds Michael O'Riordan February 23, 2016